Dr Carole Proctor Professor Doug Gray
| Investigating Interventions in Alzheimer's Disease with Computer Simulation Models | 2013 |
|
Professor Doug Gray
| Coordination of glioblastoma cell motility by protein kinase C iota | 2010 |
|
Dr Carole Proctor Professor Doug Gray
| Experimental and computational analysis of polyglutamine-mediated cytotoxicity | 2010 |
|
Dr Carole Proctor Professor Doug Gray
| GSK3 and p53 - is there a link in Alzheimer's disease? | 2010 |
|
Professor Doug Gray
| Regulation of PCNA polyubiquitination in human cells | 2010 |
|
Professor Doug Gray
| Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein | 2009 |
|
Professor Doug Gray
| FUS-immunoreactive intranuclear inclusions in neurodegenerative disease | 2009 |
|
Professor Doug Gray
| Rad18 | 2009 |
|
Professor Doug Gray
| Targeting the ubiquitin proteasome pathway for the treatment of septic shock in patients | 2009 |
|
Professor Doug Gray
| Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity | 2008 |
|
Professor Doug Gray
| Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells | 2008 |
|
Dr Carole Proctor Professor Doug Gray
| Explaining oscillations and variability in the p53-Mdm2 system | 2008 |
|
Professor Doug Gray
| hMMS2 serves a redundant role in human PCNA polyubiquitination | 2008 |
|
Dr Carole Proctor Professor Doug Gray
| An in silico model of the ubiquitin-proteasome system that incorporates normal homeostasis and age-related decline | 2007 |
|
Dr Sabine Langie Professor Doug Gray
| Formation of Lysine 63-linked poly-ubiquitin chains protects human lung cells against benzo[a]pyrene-diol-epoxide-induced mutagenicity | 2007 |
|
Professor Doug Gray
| Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitin | 2006 |
|
Professor Doug Gray
| Lysine 63-polyubiquitination guards against translesion synthesis-induced mutations | 2006 |
|
Professor Doug Gray Professor Alexander Burkle
| SENS and the polarization of aging-related research | 2006 |
|
Professor Doug Gray
| Effect of ubiquitin expression on neuropathogenesis in a mouse model of familial amyotrophic lateral sclerosis | 2005 |
|
Professor Doug Gray
| Lipofuscin and aging: a matter of toxic waste | 2005 |
|
Professor Doug Gray
| Bone marrow-derived stem cells initiate pancreatic regeneration | 2003 |
|
Professor Doug Gray
| Effects of mutant ubiquitin on ts1 retrovirus-mediated neuropathology | 2003 |
|
Professor Doug Gray
| Expression of a K48R mutant ubiquitin protects mouse testis from cryptorchid injury and aging | 2003 |
|
Professor Doug Gray
| Maneuvering for advantage: the genetics of mouse susceptibility to virus infection | 2003 |
|
Professor Doug Gray
| Stimulation of the murine Uchl1 gene promoter by the B-Myb transcription factor | 2003 |
|
Professor Doug Gray
| Ubiquitin, proteasomes, and the aging brain | 2003 |
|
Professor Doug Gray
| Analysis of ubiquitination in vivo using a transgenic mouse model | 2001 |
|
Professor Doug Gray
| Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130 | 2001 |
|
Professor Doug Gray
| Damage control – a possible non-proteolytic role for ubiquitin in limiting neurodegeneration | 2001 |
|
Professor Doug Gray
| Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents | 2001 |
|